AstraZeneca
AZN
AZN
460 hedge funds and large institutions have $11.1B invested in AstraZeneca in 2017 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 165 increasing their positions, 123 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3.15% more ownership
Funds ownership: 24.95% → 28.1% (+3.1%)
2% more funds holding
Funds holding: 449 → 460 (+11)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
460
Holding in Top 10
6
Calls
$397M
Puts
$128M
Top Buyers
| 1 | +$324M | |
| 2 | +$259M | |
| 3 | +$227M | |
| 4 |
BlackRock
New York
|
+$215M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$210M |
Top Sellers
| 1 | -$161M | |
| 2 | -$78.1M | |
| 3 | -$47.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$45.5M |
| 5 |
Renaissance Technologies
New York
|
-$38.1M |